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Abstract
Indiscriminate use of antibiotics has created a selective advantage for resistant
strains of bacteria. Resistance is spread through bacterial conjugation, whereby plasmids
that contain genes for alternate enzymes are transmitted directly between bacteria. The Rplasmid encoded enzyme R67 dihydrofolate reductase (DHFR) confers resistance to the
antibacterial drug trimethoprim. Typically, chemical screening for new drugs involves
modification of the known ligands for a given enzyme. On the other hand, novel
structures can be identified through computer screening. The program suite DOCK
developed by Irwin Kuntz, et al. at UCSF docks ligands into an enzyme of known
structure based on Van der Waals interactions. First, the program, MS, developed by
Michael Connolly, creates a surface by calculating the solvent accessible surface over the
crystal structure (obtained from the Protein Data Bank). Then SPHGEN fills the
invaginations of the active site with a set of overlapping spheres. A negative image of the
site is created from the set of sphere centers. The ligand interactions are evaluated by
constructing a grid over the protein structure using GRID. Ligands from the Cambridge
Structural Databank (CSD) were scored for Van der Waals interactions with R67 using
DOCK and the top 1000 scoring molecules were run again considering more orientations.
The top scoring compounds were identified for testing in the laboratory as potential
inhibitors of R67 DHFR.

Introduction
Antibiotic Resistance
In 1929, Alexander Fleming discovered penicillin, the first antibiotic. Initial
optimism about the universal efficacy of antibiotics led to their overuse. Antibiotics are
used as a common addition to animal feed, in order to expedite their marketability. The
indiscriminate use of antibiotics has resulted in a selective advantage for bacterial
resistance. High levels of resistance usually indicate the presence of a Resistance plasmid
or R-plasmid. Resistance plasmids are spread through the phenomenon of bacterial

conjugation, which involves the transfer of genetic material. Though it is impossible to
determine when these plasmids first evolved, there is evidence to suggest that they
predate the use of antibiotics. For example, resistance plasmids have been found in nonpathogenic soil bacteria. A selective pressure may have existed in the soil because many
antimicrobial agents such as penicillin are soil organisms. Also a strain of E. coli that was
frozen in 1946, was found to contain plasmids conferring resistance to tetracycline and
streptomycin. Neither drug was used clinically until many years later. Thus the
indiscriminate use of antibiotics has not sped the evolution of novel resistance
mechanisms, but has simply created a selective advantage for the transmission of the Rplasmids. R-plasmids contain genes that code for new proteins that either inactivate the
antibacterial drug, actively pump it out of the cell, or simply prevent its uptake. Once
these proteins are identified they become the targets for new drugs.
Traditional drug screening involves modification of the known ligands through
the addition or removal of functional groups. Though effective, this mechanism feeds the
evolution of the enzymes through mutation of the residues that interact with the ligands.
Inhibitors developed in this manner do not require a complete overhaul of the enzyme
structure to be rendered ineffective. Thus, it becomes a race between the development of
mutations within the bacteria, and the development of new drugs by the researcher (1).

A Resistance Enzyme: R67 Dihydrofolate Reductase
The enzyme dihydrofolate reductase (DHFR) converts dihydrofolate (DHF) to
tetrahydrofolate using nicotinamide adenine dinucleotide phosphate (NADPH) as a
cofactor. It thus replenishes folate cofactors required for nucleotide synthesis (2). The

chromosomal enzyme is inhibited by trimethoprim, an antibiotic administered with
sulfonamides. R67 dihydrofolate reductase, an R-plasmid encoded protein, bears no
homology to the chromosomal DHFR either in sequence or structure. Thus it confers
resistance to the antibiotic.
R67 DHFR is a roughly doughnut shaped homotetramer 30 x 35 x 40 A3 (Figure
1). A 25

A pore with 2,2,2 symmetry is found along the length of the molecule (3). The

active site pore narrows to 12 A x 9 Ain the center. Since R67 is a homotetramer, four
identical folate binding sites are expected. However, for steric reasons, only two ligands
are able to bind asymmetrically to symmetry-related binding sites (4). R67 DHFR will
bind either two folate molecules or two NADPH molecules in an unproductive complex
or one NADPH plus one folate in a productive complex. However, the binding of
NADPH inhibits the binding of a second NADPH molecule and thus facilitates the
binding of DHF to form a productive complex. There is no evidence of an induced-fit
mechanism in the binding of the ligands. Thus, R67 DHFR is a good choice for the rigid
approximation of a computational binding study.

The DOCK Program Suite
The DOCK program suite characterizes the active site of the enzyme of interest,
matches potential ligand molecules to that site, and then scores the complementarity of
the ligand to the active site (5)(6). As input, DOCK requires crystal structures of the
protein and ligand molecules, and a molecular surface file generated by Michael
Connolly's program Molecular Surface (MS).

Figure 1: R67 DHFR with Folate (bound) and NADP+ (docked).

MS estimates the solvent accessible surface of the receptor by rolling a water
molecule over the surface of the protein (7). The first DOCK program, SPHGEN, then
estimates the grooves and invaginations of this surface with a set of overlapping spheres.
It then groups these spheres into clusters. This creates a negative image of the active site
(8). Next, a scoring grid is created from the original receptor file with the program GRID
to provide a means of evaluating ligand complementarity. DOCK compares the structures
of the potential ligands to the image of the active site by comparing internal distances
based on van der Waals radii. This is known as contact scoring. The number of
orientations to be tried, and other input parameters, are specified in the dock.in file. In
addition, to contact scoring, DOCK is able to take into account chemical
complementarity, flexibility of ligand and receptor, energetic considerations, and
electrostatic interactions with the solvent and receptor molecule. With these
considerations, DOCK is able to provide more accurate predictions of ligand interactions
(9).

DOCK can be used to analyze the interaction of a known or potential ligand in
detail, or it can be used to screen a database of molecules for potential drug targets. The
following assumptions are made in the latter case: the receptor and ligands are rigid,
water and counter-ions are neglected, interaction energies are simplified. Computing time
increases enormously with the incorporation of these factors, therefore it is impractical to
consider them While screening a large number of molecules (8).

The Role of Electrostatics
Electrostatic interactions are known to play an important role in the binding of
ligands to the chromosomal DHFR in E.coli. The molecule carries a net charge of -10,
yet it binds NADPH and folate, both of which have net negative charges. An analysis of
the electrostatic charge distribution revealed a positive charge distribution at the active
site. This is thought to be a result of the presence of positively charged residues at the
entrance to the ligand binding site (10). Electrostatic potential is calculated with the
Finite Poisson Boltzmann Method.
R67 DHFR has an overall neutral charge and binds negative ligands, analysis of
the electrostatic charge distribution could help elucidate the mechanism of ligand
binding. Also, the charge distribution should be taken into account while identifying
potential ligands for docking.
The program DelPhi, developed by Barry Honig, is a finite Poisson Boltzmann
difference solver (11). It takes not only charge interactions within the macromolecule into
consideration, but also the interaction of those charges with the solvent. The presence of a
charged residue on the surface of the molecule induces a dipole moment onto nearby
solvent molecules. This induced dipole is strongest near the point charge, and decreases
with distance. The induced dipole of the solvent serves to connect areas of similar
potential.
To visualize this, DelPhi generates a potential map that can be viewed with the
molecular modeling software Insight (Biosym Technologies, San Diego, CA), in which
red is negative, white neutral, and blue positive (12). Analysis of electrostatic potential
can refine a docking search by eliminating molecules with inhibited binding.

Materials and Methods.
All programs were run on a Silicon Graphics Indigoll computer (Silicon
Graphics, Inc. Mountain View, CA). A step by step protocol is included in Appendix 1.
Preparation of Ligand Files
Potential ligand molecules from Cambridge Structural Database (13) were
screened using Quest to exclude organometallic compounds. The remaining 20,000
molecules were saved as a *.mol2 format file.
Preparation of the Receptor
Docked ligands and crystallographic waters were removed from the Protein
Databank (PDB) format receptor file in Insight. The PDB file was then run through MS,
by a DOCK accessory program called AUTOMS. Unnecessary parts of the molecule
were saved as an exclude.pdb file using another modeling program called Sybyl (Tripos,
Inc. St. Louis, MO). The output MS file was fed into SPHGEN. SPHGEN parameters
were specified in a file called INSPH (see appendix). Sphgen results were viewed using
the DOCK accessory program, SHOWSPHERE.
Unwanted sphere clusters were deleted by hand in Sybyl, and the results were
saved as a *.sph file using PDBTOSPH. Next, a scoring grid was created using GRID.
Input parameters for GRID were specified in a file called grid.in. Grid results were
viewed using SHOWBOX.
DOCK
DOCK input parameters were specified in dock.in file (see appendix).

Compounds from the CSD were then docked with R67. Fifty orientations were scored for
each crystal structure. The top 1000 scoring compounds were rerun considering 400
orientations.
For a more realistic model of ligand binding, a new Sphere file was created with
the crystallographic waters intact. Molecules from the CSD were then docked with this
new sphere cluster. Also, a mol2 file of NADP+ and of folate were created in INSIGHT
and docked with R67 as a basis for comparison. The NADP+ and folate coordinates were
obtained from the chromosomal DHFR structure.
Results were viewed by dividing the output files into manageable portions, and
viewing them in INSIGHT referenced to the R67 molecule (14). The top scoring
molecules were alphabetized using a program written by Rod Bunn (15), to create a
reference code list that could be viewed in the Cambridge Structural Database.
DelPhi Electrostatics
Electrostatic Potential Maps were created using DelPhi. The default charge and
size files obtained with the program were used. The influence of Lysine residues on the
electrostatic potential in the pore was then analyzed by removing the charge for the
amino acid in the charge file and viewing the resulting potential map. The process was
repeated for Histidine and Arginine. Alternatively, individuallysines were mutated on
the computer and replaced by methionine residues.

Results and Discussion
SPHGEN
The negative image created with SPHGEN reflects the active site symmetry of
R67 (Figures 2 & 3). Viewed from the front, the pore appears split into four chambers.
When viewed from the side the negative surface looks like two flattened cones oriented
perpendicular to one another (Figure 4). The negative surface provides a means of
visualizing the asymmetric binding of the ligands. Also, it is clear that only two ligands
can bind due to the van der Waals interactions between residues in the pore.
DOCK
Some difficulties were encountered while running GRID. It proved complicated
to limit the size of the scoring grid to only the active site of the enzyme. This may have
contributed to the length of time required to run DOCK.
Due to computational constraints, the number of heavy atoms in the ligand
molecules was limited to 50. This is unrealistic, since folate and NADP+ possess 60-70
heavy atoms.
The top scoring compound BZANTClO scored at -210. In comparison, folate,
which was scored for 400 orientations scored -106, and NADP+ scored -149. Many of
the compounds scored higher than the natural ligands, based on a comparison distances to
residues in the active site pore.
DOCK identified many modified purines and pyrimidines (Figures 5& 6). These
results were not surprising, since purines and pyrimidines are similar in structure to the
natural ligands. However, DOCK also identified compounds of novel structure such as a
crown ether (Figure 7). Upon viewing the compounds in the CSD, many were too

Figure 4: Sphere Clusters Viewed Along the Length of the Molecule

Figure 5: 3',5'-Oi-O-acetyl thymidine docked with R6? OHFR

Figure 6: Deoxycholic Acid (co-crystallized with salicylic acid)
docked with R67 DHFR

Figure 7: 15-crown-5-clathrate docked with R67 DHFR

hydrophobic to interact with R67 in solution, or were toxic and thus had to be eliminated
as potential candidates for inhibition. Mr. J. Helton screened the kinetic effect of 15crown-5 clathrate, 3' -azido-3' -deoxythymidine,deoxycholic acid, 1,4,5 ,8-naphthalene
tetracarboxylic anhydride, and 3' ,5' -di-O-acetyl thymidine on the activity of DHFR (16).
DelPhi Potential Maps
The potential map generated by DelPhi showed a concentration of positive charge
in the active site pore. Since there are no positive residues in the pore itself, the influence
of the lysine residues near the pore was analyzed. When the charge on all eight symmetry
related lysines (residues 32 and 33) is removed, the active site pore becomes red colored
(negatively charged). Thus, the presence of the Lysines is essential to the observed
charge distribution. To analyze the individual contribution of each Lysine, they were then
treated separately. When lysine 33 is removed, the charge becomes more concentrated in
the pore. This is logical since lysine 32 is physically closer to the pore. However, when
the charge on Lysine 32 is removed, a blue area is still observed in the pore. This is due
to the presence of Histidine 62. When the charge on Histidine is removed in addition to
that on Lysine 32, the blue in the pore disappears (Figure 8). Interestingly, the Arginines,
though far removed from the pore, influence the charge distribution as well. When their
charge is removed, the active site becomes neutral (white). Since they are on the outside
or the molecule, they have a greater influence on the induced dipoles in the solvent.
Additionally, arginines tend to be more exposed to solvent.

Future Studies
The Heavy Atom limit can be circumvented by dividing the database into small
portions. This is currently being done in the lab, and should result in more accurate
predictions. Some predicted compounds were also tested for inhibition (16). Lysine and
Histidine mutants were created in the lab. Kinetic studies should be done on these
mutants to determine the accuracy of the DelPhi predictions. Electrostatic considerations
should be incorporated into DOCK, as well as energy scoring and chemical matching.
Also, it is unrealistic to assume that the ligands are rigid. Use of the flexible ligand model
within DOCK should yield a more realistic representation of ligand binding.
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Appendix 1
Protocol for DOCK

Protocol for DOCK
A step by step guide for searching for potential ligands
Ingredients: A Siilcon Graphics Machine
Insight
SYBYL
DOCK
MS
The Cambridge Structural Databank
Delphi
A researcher,
A computer guy,
and ...
A student (to do things like type up this protocol) ©
To run dock, we must start with a receptor file from the protein databank. The first step is
to remove any ligands that were co-crystallized and to remove crystallographic waters.
(do this in INSIGHT)
r67 without ligands and waters lusr/people/ushmalnarayanaternaryl.pdb
r67 with ligands
lusr/people/ushmalnarayanaternary2.pdb
r67 with waters
lusr/people/ushmalnarayanaternary3.pdb
r67 with ligands and waters
lusr/people/ushmalnarayanaternary4.pdb
Next we must create a Connolly surface using the program MS (molecular surface) from
the QPCE (Quantum Program Chemistry Exchange).
go to lusr/people/ushmalconollysurf
Dock will automatically run MS and create at dock input file using the program AutoMS.
However AutoMS has a fatal program error. A corrected copy of the program is included
with MS. The file is called DOCK_interface(Cf:IECKPA'JlN). We can find the
differences between the two programs with the unix difference command:
$diff DOCK_interface lusr/datalushmaldock4lbinlautoMS
Using jot, we then update the paths in the DOCK_interface file and take off the header.
save as autoMS.
dock_root= lusr/datalushmaldock4lbin
MS_executable= lusr/people/ushmalconnollysurf/429_sgrw/connolly
(AutoMS requires an extract.pdb file to run.)
First we must exclude all portions of the molecule that are irrelevant to our search. We do
by creating an exclude.pdb file using the molecular modeling program SYBYL. We use
SYBYL remotely on Dr. Baker's machine in the Chemistry Department. To go to Dr.
Bakers machine:

$xhost +
$telnet sugar.chem.utk.edu
login: howell
password: folate 1
$sybyl
This will bring up the SYBYL program.
Under the file tab select read
Select the desired pdb file (see sybyl files list)
When asked if the molecule should be centered, select yes.
In order to create a shell that encompasses a spherical or symmetrical active site, we must
add a raw atom to the center of the active site. Select C3.
For the coordinates enter (0,0,0) since we want the molecule in the center of the active
site.
Go the extract command
When prompted to select atoms select the center atom we added by clicking on it.
Then hit the sets tab on the extract command window. Select sphere.
Enter a radius of 15 angstroms. (Adjust this to include whatever parts of the molecule are
of interest).
Then hit the invert tab. It will ask where you wish to put the extracted atoms. Put them in
M2 (molecular area two). Save M2 as a Brookhaven file called exclude.pdb (Be sure to
rename any old exclude.pdb files you may want to keep).
Use xftp to move the files from sugar to how2.bio.utk.edu. Put in
lusrldatalushmaldock4/bin
Log off of Dr. Baker's machine. Look at the created file in INSIGHT.
$cd lusr/datalushmaldock4/bin
$autoMS lusr/people/ushmalnarayanaternary 1. pdb
• location of receptor pdb file
The output file should have the extension *.ms.
The screen should read: Ready to run SPHGEN
Now we must create an INSPH File! Using jot, type the following (excluding the parts in
parentheses). Modify as needed. For an explanation of the values see the DOCK manual
p.84.

/usr/people/ushma/narayanatemaryl.ms (~MS output file)
R
X
0.0
4.0
/usr/people/ushma/narayanatemary1.sph (~ Sphgen output file name)
$sphgen
It takes a while to run, so this is a good time for a snack. ©
The OUTS PH file contains useful information including the number of sphere clusters
generated.
density type = X
reading /usr/people/ushma/narayanatemary3.ms
# of atoms =2000
# of surf pts =21996
finding spheres for /usr/people/ushma /narayanatemaryl.ms
dotlim = 0.000
radmax = 4.000
Minimum radius of acceptable spheres?
1.400000
output to /usr/people/ushma/narayanatemary 1.sph
clustering is complete 27 clusters

There are probably more sphere clusters thatn you need. We can visualize the sphere
clusters using the program showsphere. It is interactive.
$showsphere
the input is as follows:
/usr/people/ushma/narayanatemary 1.sph

o
n

/usr/people/ushma/showsphere. pdb
Transfer the created showsphere file to Dr. Baker's machine so that it can be viewed with
SYBYL.
Unwanted Spheres must be removed by hand. Choose the EXTRACT command, click
on atoms, then sets, choose sphere with a radius of 1-3 angstroms. Invert. Save as another
molecule (Ml or M2 whichever is unoccupied). Now zap the first Molecular area. The
second area now contains the molecule minus the selected sphere clusters. Repeat this
process until all unwanted clusters have been removed. Rinse Gust kidding). Save the
number cluster file with an appropriate name (eg. reducedsph.pdb).

FrP the new file back to how2.bio.utk.edu. Place in
/usr/datalushmaldock4lbin/(filename).
Run pdb to sph to change the file into the sphere format required by dock
$pdbtosph
input file:
output file:

reducedsph. pdb
reducedsph.sph

Next we must create a scoring grid, using GRID.
See p.80 of the Dock reference manual.
Read the receptor file into INSIGHT, Set the potentials, add H's, and charges. Modify the
hydrogens and fix forcefield potentials. Using Molecule/put save the receptor as a mo12
file. (this takes a while to save)
Run using created box file box.pdb . The following is sample input for GRID.
compute_grids
outpucmolecule
grid_spacing
contacCscore
contacCcutofCdistance
chemicaLscore
energy_score
bump_filter
bump_overlap
receptocfile
box_file
vdw _definition_file
score_grid_prefix

yes
no
0.3
yes
4.5
no
no
yes
0.75
lusr/people/ushmalnarayanaternary l.mol2
/usr/datalushmaldoc4lbinlbox. pdb
lusr/datalushmaldock4/parameter/vdw.defn
grid2

The Grid Command line is $grid -i grid.in
GRID takes a really long time to run and the output file size is quite large.
Look at the GRID output using showbox. This is also an interactive program.
The output when viewed in Insight, should encompass all areas of the molecule that are
of interest. Reference the grid file to the receptor file for comparison.
(Yes, it's supposed to be a boring yellow box)
PREP~RE

LIGi\:NDFILE in Cambridge.
$cd /usr/dataiCAMBRIDGE
$setenv CSDHOME 'pwd'
$set path = ($CSDHOMElbin Spath)
$rehash
$cd trials
$ls

$quest trialx (where x is the next number after the last trial in this directory)
$term x
$menu
The x-windows version of Cambridge should appear. Click in the window to begin. Go to
the TO SEARCH tab in the upper right hand corner. Choose NUMERICAL. Go to
CLASS enter RANGE and enter 1-64. Then return to the main menu. Save as mol2 and
as REFCODE LIST. Go to the QUEST ... command and selected the 1-64 search and hit
ONLY ORGANICS. Then hit startsearch. When the first result comes up, click DIAG
with the right mouse button (this speeds up anything done with the left mouse button).
The compounds should flash on the screen very rapidly. (This is neat to watch, but takes
a couple of hours). At the end, the message End of Database Encountered! comes up and
you are asked if you want to quit. Say yes. Once you are out of Cambridge check to see
that a trialx.mo12 and a trialx.gcd file have been created, by using the unix list command:
$ls This mo12 file will be the ligands file for DOCK.

Now we are (finally) ready to run DOCK!!! (a dance of joy may be appropriate)

First we must create an dock.in file.
here is a sample file:
flexible_ligand
orienCligand
score_ligand
minimize_ligand
multiple_ligands
parallel.Jobs
random_seed
match_receptocsites
random_search
automated_matching
maximum_orientations
write_orientations
rank_orientations
rank_orientations_total
intermolecular_score
gridded_score
grid_version
bump_filter
bump_maximum
contacCscore
chemical_score
energy_score

no
yes
yes
no
no
no

o

yes
no
yes
50
yes
yes
10
yes
yes
4
yes

3
yes
no
no

atom_model
vdw_scale
electrostatic_scale
ligands _maximum

intial_skip
interval_skip
heavy_atoms_minimum
heavy_atoms_maximum
rank_ligands
rank_ligands_total
restart_interval
ligand_atom_file
receptor_site_file
score_grid_prefix
vdw_definition_file
quicfile
dump_file
info_file
restart_file
manual)
contacCclash_penalty
ligand_contacCfile
ligand_centers

u

1
1
20000 (note: this number must be larger than the
total number of molecules in the ligands file)

o
o

4
40
(this limits the time that the run takes)
yes
1000
100
lusr/datalCAMBRIDGE/trials/trial2.mol2
(change this to subset)
lusr/people/ushmalnarayanaternary3. sph
grid3
lusr/datalushmaldock4/parameter/vdw .defn
(this file is provided with dock. The path MUST be correct)
docklS.quit
docklS.dump
docklS.info
docklS.rst (restart commands are in the DOCK

SO
dock_cnt1S.moI2 (this is the results file)
no

The DOCK command line is:
$dock -i dock.in
This gives the top 1000 scoring ligands. We then reran these thousand with more
orientations.
These parameters have to be changed:
400
maximum_orientations
ligands_maximum
1000

To view the results:
First, convert the dock.info (save to disk and move to the Gateway Computer) file to a
REFCODE list for Cambridge, using Rod's program.
Click on DOCK_converter
Go to Filel Alpha
Put source file name in source Box.
Then Select files and save conversions
It should read finished when its done.
save file as trialx.gcd

$cd lusr/dataJCAMBRIDGE
$setenv CSDHOME 'pwd'
$set path =($CSDHOMElbin $path)
$rehash
$cd trials
$setenv CSDVIRTDB trialx.gcd
$quest trial(x+l)
At this point you should see information about the Cambridge Strucutural Databank flash
acroos the screen.
Near the top it should say: search being run on VIRTDB trialx
(this greatly speeds up the viewing process)
$term x
$menu
[to remove the virtual database option, type unsetenv CSVIRTDB]
Now the x-windows version of CSD appears. Click in the window to begin.
In the upper right hand corner, click on TO SEARCH
From the search options choose TEXT
From the text options choose REFCODE
Enter the reference codes (eg. BZANTC 10) one by one for the compounds that you wish
to view.
When you are done return to the main menu.
Go to the QUEST ... option. You should see a REFCODE list. Choose only organics on
the right side's menu. Select 1 of the refcodes listed. Then hit SEARCH. The selected
compounds will appear on the screen. Go to view ID to see the compounds chemical
name.
Hit reject from the 2D/3D option. It will then tell you: End of Database Encountered! Do
you wish to exit? If you do not exit at this point you will lose all hits from this search!
Enter no. (This is a flaw in the program. There must be a way to save the compounds that
you like from the reference list, but I haven't been able to do it without getting this
message.)
Then repeat with each of the compounds of interest.
When you are ready to exit Cambridge, go to the exit option on the main menu.
To view the results oriented to the receptor:
$cd lusr/dataJushmaJdock4lbin
The dock_cnt.moI2 files are too big to open!!! Split them up using the program from
Tina Yeh at Biosym.
See Media.Mail forinstructions
The program is in lusr/dataJushmaJdockrunl called renamefiles.
$mkdir lusr/dataJushmaJdockrunx
$ cp lusrldataJushmaJdockrun l/renamefiles lusrldataJushmaJdockrunxlrenamefiles
$cp lusr/dataJushmaJdock4lbinidock_cntx.moI2
lusr/dataJushmaJdock4/dockrunx/dock_cntx.moI2

Now we have to change the access mode to the new folder.
$chmod -R u+rwx /usr/dataJushmaJdockrunx
:/" {49} ,
$csplit -f dock_cnCnew dock_cntx.mo12 '!Number
• (six spaces)
$renamefiles dock_cnCnew .mol2
jot to open and check files for refcodes of interest.
Go into Insight. Molecule-7get-7 narayanatemaryl.pdb
Get the compounds of interest from /usr/datalushmaldockrunx
Pull them up while referencing the receptor molecule.
Save images if desired.
Delphi Electrostatics
To create the delphi potential map:
$ cd /usr/dataldelphilexport
The charge file and parameter file must be modified.
$cd /usr/dataldelphi/export/examples/SOD
$ls
$jot r67.prm
An example parameter file:
scale=O.8
perfil=80
in (pdb, file= "/usr/people/ushmalnarayanatemaryl.pdb")
in (crg, file="examples/SOD/r67.crg")
in (siz, file="examples/SOD/sod.siz")
out (modpdb, file="r67 _delphi.pdb")
out (phi, file="r67 .grd", form="BIOSYM")
energy (c,s)
Change the parameter file. Make sure that the output file extension is *.grd, so that it can
be viewed with Insight. The size (*.siz) file is based on Van der Waals Radii and does not
need to be modified.
The charge file should be adapted for the molecule of interest.
Go back to (*crg) /usr/dataldelphi/export
The command line of Delphi is as follows:
$delphi examples/SOD/parameterfile.prm > logfile.log
[look at the logfile to make sure it ran]
Viewing the results:
Enter Insight. Pull up receptor molecule with Molecule/ get. Use Molecule/color to
change backbone color to gray or white. The go to the third icon on the left side of the
screen and click. Pull in *.grd file from /usr/dataldelphilexport . A yellow box should
appear. Then graphically create a connolly surface by going to Molecule/Surface. Select
low resolution or it will take Y2 hour to load. To Color the surface go to Molecule/Color.
Under attribute choose surface. Under Color Method choose grid. Under Spectrum Name
choose Delphi_Spectrum. This will display the potential map.

